Acasti Pharma | ACST - Cash And Equivalent

Stock Price
4.07
Daily Change
-1.06 -20.66%
Monthly
3.56%
Yearly
126.11%
Q2 Forecast
5.00

Acasti Pharma reported $16.86M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Acasti Pharma USD 16.86M 3.14M Sep/2025
Addus HomeCare USD 81.62M 20.3M Dec/2025
Amarin USD 122.8M 25.08M Sep/2025
Cassava Sciences USD 106.08M 6.3M Sep/2025
Knight Therapeutics CAD 76.45M 5.43M Dec/2025
Option Care Health USD 232.62M 77.2M Dec/2025
Organigram Holdings CAD 7.58M 20.62M Dec/2025
Tilray USD 264.83M 43.16M Jun/2025